Screener
CryoPort, Inc. CYRX Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by CryoPort, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: CryoPort, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092107
FAQ
- What is CryoPort, Inc.'s cash & equivalents?
- CryoPort, Inc. (CYRX) reported cash & equivalents of $269.27M in Q2 2026.
- How has CryoPort, Inc.'s cash & equivalents changed year-over-year?
- CryoPort, Inc.'s cash & equivalents increased by 10.6% year-over-year, from $243.42M to $269.27M.
- What is the long-term trend for CryoPort, Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), CryoPort, Inc.'s cash & equivalents has grown at a 46.7% compound annual growth rate (CAGR), from $36.87M to $250.49M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about CryoPort, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude